XML 30 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Balance (in shares) at Dec. 31, 2022   107,673,052      
Balance at Dec. 31, 2022 $ 502,125 $ 108 $ 1,055,048 $ (9,557) $ (543,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 139,819   139,819    
Common stock issued under employee stock plans (in shares)   2,931,316      
Common stock issued under employee stock plans 12,649 $ 2 12,647    
Taxes related to net share settlement of equity awards (21,415)   (21,415)    
Repurchase of common stock (in shares)   (1,500,647)      
Repurchase of common stock (43,522) $ (1) (43,521)    
Unrealized (loss) income on derivative instruments, net of tax (1,040)     (1,040)  
Unrealized income (loss) on available for sale securities, net of tax 1,948     1,948  
Net loss (100,916)       (100,916)
Balance (in shares) at Dec. 31, 2023   109,103,721      
Balance at Dec. 31, 2023 489,648 $ 109 1,142,578 (8,649) (644,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 126,682   126,682    
Common stock issued under employee stock plans (in shares)   3,397,390      
Common stock issued under employee stock plans 16,082 $ 3 16,079    
Taxes related to net share settlement of equity awards (38,295)   (38,295)    
Unrealized (loss) income on derivative instruments, net of tax 15,423     15,423  
Unrealized income (loss) on available for sale securities, net of tax (4,098)     (4,098)  
Common stock issued for debt conversion (in shares)   49,045      
Common stock issued for debt conversion 1,501 $ 1 1,500    
Purchase of capped calls related to Convertible senior notes (55,522)   (55,522)    
Net loss (95,765)       (95,765)
Balance (in shares) at Dec. 31, 2024   112,550,156      
Balance at Dec. 31, 2024 455,656 $ 113 1,193,022 2,676 (740,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 130,242   130,242    
Common stock issued under employee stock plans (in shares)   2,344,025      
Common stock issued under employee stock plans 14,349 $ 2 14,347    
Taxes related to net share settlement of equity awards (29,162)   (29,162)    
Repurchase of common stock (in shares)   (2,928,780)      
Repurchase of common stock (115,000) $ (3) (114,997)    
Unrealized (loss) income on derivative instruments, net of tax 16,532     16,532  
Unrealized income (loss) on available for sale securities, net of tax 3,924     3,924  
Common stock issued for debt conversion (in shares)   8,185,885      
Common stock issued for debt conversion 251,439 $ 8 251,431    
Settlement of capped call transactions (in shares)   (2,604,434)      
Settlement of capped call transactions 0 $ (2) 2    
Net loss (129,324)       (129,324)
Balance (in shares) at Dec. 31, 2025   117,546,852      
Balance at Dec. 31, 2025 $ 598,656 $ 118 $ 1,444,885 $ 23,132 $ (869,479)